We want to improve the treatments
with the development of predictive methods that allow the personalization and precision
We believe in a sustainable digitization of the medical sector, where obtaining Real World Evidence thanks to the implementation of Artificial Intelligence (AI) systems , will allow better decisions to be made, not only based on intuition, but also on data and positioning the patient at the center of clinical action.
About us
Current medicine is in a paradigm shift by the introduction of new treatments based on regenerative medicine, the incorporation of the digitization in medicine and society in general as well as the search for new methods of collaboration and the personalization of treatments to their patients.
In 2021 we put our product on the market PRP data (more information >), a system to implement the investigation of PRP (Platelet Rich Plasma) by the hand of the Real World Evidence, incorporating quality systems, clinical monitoring and regulatory control to the regenerative medicine market.
During this journey, we continue to work with our clients in obtaining data from real clinical evidence in order to correctly evaluate the
effectiveness of their treatments, develop new innovative protocols and devise disruptive projects in the health sector, collaborating from technical development and regulation to the marketing and marketing of products.
Our pathway
Aug 2020
The TODO Biomedical Consulting Group is founded, the company that will develop the PRP data project, thanks to the support of its partners.
Sep 2020
The process of development of the PRP Data application after months of deciding on the process and establishing the appropriate processes for the application.
Jan 2021
The first version (PMV Minimum Viable Product) of the PRP Data application, with our first clients (early adopters).
May 2021
Obtaining financing with a guarantee from the Basque Country's reciprocal guarantee institution -
Elkargi
Sep 2021
official release of the PRP Data application to the market, with the incorporation of new clients.
Creation of alliances with SETRADE (Spanish Society of Traumatology and Sports) and creation of the first study group observations of the use of Platelet Rich Plasma using PRP Data.
2022
An active marketing process of the system is carried out, incorporating new clients and seeking continuous improvements.
The ORBIT (Orthobiologics Initiative) consensus of ESSKA (European Society of Sports Traumatology, Knee Surgery & Arthroscopy) was reached out to, indicating the need to establish a standardisation model for the use of PRP (Platelet Rich Plasma).
Collaboration agreement for the commercialisation of new haematological counters with Menarini Diagnostics at national level, which facilitates the entry of new customers
Jan 2023
Enisa opens the way for financing through the Emprendedoras Digitales line for the continued development of software.
Initiation of the opening of the system to other treatments, sectors and specialities. The process of changing from PRP Data to BioSmart Data begins.
Incorporation into the bioib cluster: Biotechnological and biomedical cluster of the Balearic Islands
May 2023
The BioSmart Data project is presented to Neotec, a public state aid for the development of projects where collaboration is initiated for the development of Artificial Intelligence Algorithms for the objectives of precision, prediction and prescription.
Our Team
Innovation is not a matter of money, it is a matter of people
BioSmart Data is made up of a multidisciplinary team prepared, motivated, united and experienced, with the vision of being part of the change that is taking place in the current healthcare model, where throughout the innovation process the patient is at the center of the strategy.
If you wish to work with us, please send an email to:
info@biosmartdata.eu
A WAY OF MAKING EUROPE:
TODO Biomedical Consulting Group SL with its PRP Data project within the framework of the ICEX Next Program, has had the support of ICEX and co-financing from the European fund FEDER European Fund for regional development. The purpose of this support is to contribute to the international development of the company and its environment.
